GlobalRPH - Endocrinology News

Medical News

< back to feeds
Endocrinology News
Economics, Neuroscience And Hormones Workshop A workshop on "Neuroeconomics and Endocrinological Economics," being held Nov. 20 and 21 at UC Davis, will be the first to bring together experts in neuroscience, economics and hormone physiology in one event, according to organizers. Neuroeconomics has emerged as a new field in recent years, as both economists and neuroscientists have used brain scanning technology such as functional magnetic resonance imaging to investigate how people make decisions. ...more	20 Nov 2009
Effects Of Vitamin D Deficiency Amplified By Shortage Of Estrogen Researchers at Johns Hopkins are reporting what is believed to be the first conclusive evidence in men that the long-term ill effects of vitamin D deficiency are amplified by lower levels of the key sex hormone estrogen, but not testosterone. In a national study in 1010 men, to be presented Nov. ...more	17 Nov 2009
Heart And Bone Damage From Low Vitamin D Tied To Declines In Sex Hormones Researchers at Johns Hopkins are reporting what is believed to be the first conclusive evidence in men that the long-term ill effects of vitamin D deficiency are amplified by lower levels of the key sex hormone estrogen, but not testosterone. In a national study in 1010 men, to be presented Nov. ...more	16 Nov 2009
Esperion Therapeutics Initiates Phase I Clinical Study For ETC-1002 Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, announced that the company has initiated a Phase I clinical study for ETC-1002, the company's novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins. ...more	14 Nov 2009
FDA Approves Lysteda To Treat Heavy Menstrual Bleeding The U.S. Food and Drug Administration approved Lysteda tablets (tranexamic acid), the first non-hormonal product cleared to treat heavy menstrual bleeding (menorrhagia). Lysteda works by stabilizing a protein that helps blood to clot. Heavy menstrual bleeding is reported each year by about 3 million U.S. women of reproductive age. Women with uterine fibroids may experience heavy menstrual periods. ...more	14 Nov 2009
The 'Love Hormone,' Also Affects Antisocial Behaviors, Such As Envy And Gloating A new study carried out at the University of Haifa has found that the hormone oxytocin, the "love hormone", which affects behaviors such as trust, empathy and generosity, also affects opposite behaviors, such as jealousy and gloating. ...more	14 Nov 2009
LA BioMed To Launch Study Of Testosterone In Older Men Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) has announced that it will participate in a large national study of the effectiveness of testosterone as a treatment for anemia, cardiovascular disease, decreased vitality, impaired memory and sexual function, loss of muscle mass and other health conditions that affect older men. ...more	14 Nov 2009
What Is Short Stature (Dwarfism)? What Causes Short Stature? Dwarfism, nanism, short stature, or restricted growth is a medical disorder in which the person is of abnormally short stature. According to various sources, short stature may be caused by over 200 different medical conditions. According to the LPA (Little People of America), dwarfism is defined as an adult height of 4 feet 10 inches (148 cm) or less. However, as population groups around the world have varying average statures, height definition may vary. ...more	13 Nov 2009
AMA Adopts Endocrine Society Resolution Opposing Medicare's Proposal To Eliminate Payments For Specialists The American Medical Association's (AMA) House of Delegates adopted a resolution opposing all public and private payer efforts to eliminate physician consultation services. Physicians providing inpatient and outpatient consultation services play a crucial role in diagnosing and caring for patients with complex medical conditions. ...more	12 Nov 2009
Testing New Treatments For Severe H1N1 Infection Quick 'bench-to-bedside' clinical trial would enroll 1,400 influenza patients to test corticosteroids and statins as potential treatments An important, ground-breaking initiative is unfolding in the global critical care community in response to the H1N1 pandemic. ...more	12 Nov 2009
AMA Adopts Endocrine Society Resolution Calling For New Policies To Decrease Public Exposure To Endocrine-Disrupting Chemicals The American Medical Association's (AMA) House of Delegates adopted a resolution calling on the AMA to work with the federal government to enact new federal policies to decrease the public's exposure to endocrine-disrupting chemicals (EDCs). The resolution, introduced by The Endocrine Society, reflects the findings and recommendations of The Endocrine Society's peer-reviewed Scientific Statement ( ...more	11 Nov 2009
New Key To The Puzzle Of Hormone Therapy And Breast Cancer Uncovered By Scientists The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. "Postmenopausal hormone treatment is associated with increased rates of benign breast biopsies, and early and late stages of cancer. ...more	10 Nov 2009
Thyroid Journal Publishes Newly Revised Guidelines For Managing Thyroid Cancer The American Thyroid Association has released new, revised Management Guidelines for the diagnosis and treatment of patients with thyroid nodules and thyroid cancer. The new guidelines are published in Thyroid, a peer-reviewed journal published by Mary Ann Liebert, Inc. Thyroid is the official journal of the American Thyroid Association (ATA). The ATA's revised Management Guidelines and accompanying editorials are available free online at ...more	10 Nov 2009
The Consumption Of Melatonin, A Natural Hormone Segregated By The Own Human Body, Regulates Sleep Better Than Somniferous Melatonin, a natural hormone segregated by the own human body, is an excellent sleep regulator expected to replace somniferous, which are much more aggressive, to correct the sleep/wakefulness pace when human biological clock becomes altered. ...more	10 Nov 2009
What Is Graves' Disease? What Causes Graves' Disease? Graves' disease is an autoimmune disease in which the patient's own immune system attacks the thyroid gland, causing it to produce too much thyroxine. Thyroxine (T4) is a hormone produced by the thyroid gland that has four iodine molecules attached to its molecular structure. T4, as well as other thyroid hormones help regulate growth and control metabolism in the body. Graves' disease is a form of hyperthyroidism. ...more	10 Nov 2009
Scientists Successfully Reprogram Blood Cells To Correct Lysosomal Storage Disease Researchers have transplanted genetically modified hematopoietic stem cells into mice so that their developing red blood cells produce a critical lysosomal enzyme preventing or reducing organ and central nervous system damage from the often-fatal genetic disorder Hurler's syndrome. The research team from Cincinnati Children's Hospital Medical Center reports its preclinical laboratory results this week in the early edition of Proceedings of the National Academy of Sciences. ...more	10 Nov 2009
Key To Social Behavior Is Hormone That Affects Finger Length The hormones, called androgens, are important in the development of masculine characteristics such as aggression and strength. It is also thought that prenatal androgens affect finger length during development in the womb. High levels of androgens, such as testosterone, increase the length of the fourth finger in comparison to the second finger. ...more	05 Nov 2009
To Provide Stroke Protection, Estrogen Therapy Probably Needs To Be Given Soon After Menopause For estrogen replacement to provide stroke protection, it likely must be given soon after levels drop because of menopause or surgical removal of the ovaries, scientists report in the Journal of Neuroscience. ...more	05 Nov 2009
Reduction In Glycotoxins From Heat-Processing Of Foods Reduces Risk Of Chronic Disease And Restores Innate Biological Defense Mechanisms Researchers from Mount Sinai School of Medicine report that cutting back on the consumption of processed and fried foods, which are high in toxins called Advanced Glycation End products (AGEs), can reduce inflammation and actually help restore the body's natural defenses regardless of age or health status. These benefits are present even without changing caloric or nutrient intake. ...more	04 Nov 2009
Postmenopausal Women With Higher Testosterone Levels May Have Increased Health Risks Postmenopausal women who have higher testosterone levels may be at greater risk of heart disease, insulin resistance and the metabolic syndrome compared to women with lower testosterone levels, according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM). This new information is an important step, say researchers, in understanding the role that hormones play in women's health. ...more	04 Nov 2009
Pages of Results: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 [Next] [Last Page]
Endocrinology News courtesy of Medical News Today	back to top

Medical News

Looking for a Job?

Career Center

Popular Tools

Disclaimer Contact Us Privacy Policy Website Search	We comply with the HONcode standard for health trustworthy information: Verify here. Copyright © 2007 GlobalRPh Inc.